Esperion Therapeutics
ESPR
#8329
Rank
C$0.23 B
Marketcap
$1.18
Share price
-10.32%
Change (1 day)
-55.08%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): C$9.08 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.33 Billion. , an increase over its 2023 earnings that were of -C$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 C$10.38 M-104.99%
2023 -C$0.21 Billion-15.03%
2022 -C$0.25 Billion-20.61%
2021 -C$0.31 Billion84.28%
2020 -C$0.17 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.28 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$68.16 Million36.45%
2014 -C$49.96 Million43.55%
2013 -C$34.8 Million145.26%
2012 -C$14.19 Million
2002 -C$40.45 Million-7.81%
2001 -C$43.88 Million15.03%
2000 -C$38.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.7 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.74 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.37 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.61 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$39.79 Million-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.28 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA